ArticleVaccines2020

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age.

Joanne Langley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.